Those diagnosed in stage 4 who decide against treatment live an average of 6 months. Researchers use tumor grading to estimate how fast a tumor may grow. Cell abnormalities and how rapidly the cancer cells are dividing play a role in overall tumor growth. These factors are associated with survival.